title: Coagulation: consultative hemostasis.
abstract: Clinical hematologists are frequently consulted for the care of hospitalized patients with complicated coagulopathies. This chapter provides an update on the scientific and clinical advances noted in disseminated intravascular coagulation (DIC) and discusses the challenges in hemostasis consultation. In Section I, Dr. Marcel Levi reviews advances in our understanding of the pathogenic mechanisms of DIC. Novel therapeutic strategies that have been developed and evaluated in patients with DIC are discussed, as are the clinical trials performed in patients with sepsis. In Section II, Dr. Lawrence Leung provides an overview of the challenging problems in thrombosis encountered in the inpatient setting. Patients with deep vein thrombosis that is refractory to conventional anticoagulation and those with extensive mesenteric thrombosis as well as the evaluation of a positive PF4/heparin ELISA in a post-operative setting are discussed. Novel treatments for recurrent catheter thrombosis in dialysis patients is addressed as well. In Section III, Dr. Julie Hambleton reviews the hemostatic complications of solid organ transplantation. Coagulopathy associated with liver transplantation, contribution of underlying thrombophilia to graft thrombosis, drug-induced microangiopathy, and the indication for postoperative prophylaxis are emphasized. Dr. Hambleton reviews the clinical trials evaluating hemostatic agents in patients undergoing liver transplantation.
authors.affiliation: Hemostasis and Thrombosis, Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, 94143, USA.
authors.forename: Julie
authors.initials: J
authors.lastname: Hambleton
authors.forename: Lawrence L
authors.initials: LL
authors.lastname: Leung
authors.forename: Marcel
authors.initials: M
authors.lastname: Levi
mesh_terms: D004211:Disseminated Intravascular Coagulation / Q000150:complications / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D006487:Hemostasis; D006801:Humans; D016031:Liver Transplantation / Q000009:adverse effects* / Q000379:methods; D012017:Referral and Consultation; D018805:Sepsis / Q000209:etiology; D013927:Thrombosis / Q000150:complications / Q000175:diagnosis* / Q000628:therapy